Evidence map›Paper›PMID 38958131›Full record

ArticleHuman brain mapping2024

Dynamic properties in functional connectivity changes and striatal dopamine deficiency in Parkinson's disease.

Adrian L Asendorf, Hendrik Theis, Marc Tittgemeyer, Lars Timmermann, Gereon R Fink, Alexander Drzezga, Carsten Eggers, Marina C Ruppert-Junck, David J Pedrosa, Merle C Hoenig and 1 more

Abstract read
In one paragraph

Article in Human brain mapping, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Diagnosis and Management of Parkinson Disease in Individuals with Pre-Existing Mood Disorders.International journal of environmental research and public health · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Adrian L AsendorfDepartment of Nuclear Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Hendrik TheisDepartment of Nuclear Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Marc TittgemeyerMax Planck Institute for Metabolism Research, Translational Neurocircuitry Group, Cologne, Germany.
Lars TimmermannDepartment of Neurology, Marburg, Germany.
Gereon R FinkDepartment of Neurology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Alexander DrzezgaDepartment of Nuclear Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Carsten EggersDepartment of Neurology, Marburg, Germany.
Marina C Ruppert-JunckDepartment of Neurology, Marburg, Germany.
David J PedrosaUniversities of Marburg and Gießen, Center for Mind, Brain, and Behavior-CMBB, Marburg, Germany.
Merle C HoenigDepartment of Nuclear Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Thilo van EimerenDepartment of Nuclear Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.ORCID 0000-0002-6951-2325

Funding

Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) 413543196Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) 431549029
6 · The paper itself

Abstract

Recent studies in Parkinson's disease (PD) patients reported disruptions in dynamic functional connectivity (dFC, i.e., a characterization of spontaneous fluctuations in functional connectivity over time). Here, we assessed whether the integrity of striatal dopamine terminals directly modulates dFC metrics in two separate PD cohorts, indexing dopamine-related changes in large-scale brain network dynamics and its implications in clinical features. We pooled data from two disease-control cohorts reflecting early PD. From the Parkinson's Progression Marker Initiative (PPMI) cohort, resting-state functional magnetic resonance imaging (rsfMRI) and dopamine transporter (DaT) single-photon emission computed tomography (SPECT) were available for 63 PD patients and 16 age- and sex-matched healthy controls. From the clinical research group 219 (KFO) cohort, rsfMRI imaging was available for 52 PD patients and 17 age- and sex-matched healthy controls. A subset of 41 PD patients and 13 healthy control subjects additionally underwent

Indexed as

Corpus StriatumDopamineDopamine Plasma Membrane Transport ProteinsMagnetic Resonance ImagingParkinson DiseasePositron-Emission TomographyTomography, Emission-Computed, Single-PhotonAgedCohort StudiesConnectomeDihydroxyphenylalanineFemaleHumansMaleMiddle AgedNerve NetDihydroxyphenylalanineDopamineDopamine Plasma Membrane Transport Proteinsfluorodopa F 18DAT SPECTdynamic functional connectivityF‐DOPA PETimagingnetworkresting‐state fMRI

Identifiers

PMID38958131
PMCPMC11220510

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.